LEGGETT & PLATT INC
boothcheck covers LEGGETT & PLATT INC (LEG) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed June 27, 2026.
• Leggett & Platt has agreed to be acquired by Somnigroup in an all-stock merger, with LEG holders set to receive 0.1455 Somnigroup shares per LEG share, so the stock now trades largely as a claim on that deal rather than on its own future. • The standalone business is under real pressure: trade sales fell 10% in the most recent quarter and the company says weak demand has ⟦"impacted approximately 30% of our sales"⟧, with the U.S. bedding market especially soft. • The decisive event is the merge
Is LEG overvalued? See what's priced in →
342 institutional managers reported holding LEG in 13F filings for the quarter ended 2026-03-31. Together they hold about 82% of the company; the top 10 hold 47%. 54 opened new positions that quarter. Held by BlackRock, Vanguard Group, State Street, among others. On the short side, 16.9M shares were sold short as of the 2026-06-15 count, about 12% of shares outstanding (6.9 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
LEG's share count grew 2.2% over the past five years even with $80.30M spent on repurchases. It pays a dividend, and has paid one every year in our records (17 and counting); the current rate is $0.20 a share annually. Cash returned over the past three years: $292.60M in dividends and $11.80M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at LEG over the trailing three years: 2024: 7 buys totaling $773k. 17 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
LEG's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-09 | +3.4% | -13.8% |
| 2023-11-08 | +1.1% | +12.0% |
| 2024-02-28 | -11.6% | -35.6% |
| 2024-05-09 | -27.7% | -6.5% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
LEG's latest 8-K filings: 2026-06-04 (items 8.01); 2026-05-22 (items 1.02, 5.02, 5.07, 9.01); 2026-05-07 (items 2.02, 7.01, 9.01); 2026-04-13 (items 1.01, 7.01, 9.01); 2026-02-24 (items 5.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.